Literature DB >> 29400660

Plasma exosomes as novel biomarker for the early diagnosis of gastric cancer.

Jianjun Wang1,1, Yuanyuan Liu1,1, Wangwei Sun1, Qinghui Zhang1, Tao Gu1, Guangxin Li2.   

Abstract

Exosomes are lipid bilayer vesicles of endocytic origin ranging from 30 to 100 nm in size, and contain various nucleic acid molecules such as DNA, mRNA, miRNA, lncRNA and multiple proteins, which could be transferred into target cells. Recent study indicated that exosomes as information carriers between cells has introduced us to a new previously unknown biological communication system. Increasing evidences show that exosomes play a crucial role in gastric cancer because they are potential to influence normal cellular physiology and promote various states of the cancer. In this review, we focus on the latest findings on exosomes in the plasma of gastric cancer patients, mainly summarizing the functions of miRNAs, lncRNAs and multiple proteins in diagnosis, prognosis, and in establishing treatment regimens against gastric cancer. Furtherly, potential functions of exosomes as novel diagnostic biomarkers for gastric cancer are discussed extensively. Exosomes are believed to be a non-invasive disease biomarker with a dual capability to provide insights into the early diagnosis for gastric cancer.

Entities:  

Keywords:  Exosomes; biomarker; gastric cancer; lncRNA; miRNA

Mesh:

Substances:

Year:  2018        PMID: 29400660     DOI: 10.3233/CBM-170738

Source DB:  PubMed          Journal:  Cancer Biomark        ISSN: 1574-0153            Impact factor:   4.388


  13 in total

Review 1.  Exosomes Promote Pre-Metastatic Niche Formation in Gastric Cancer.

Authors:  Jing Gao; Song Li; Qian Xu; Xue Zhang; Miao Huang; Xin Dai; Lian Liu
Journal:  Front Oncol       Date:  2021-05-24       Impact factor: 6.244

Review 2.  Circulating exosomal miRNAs and cancer early diagnosis.

Authors:  L Zhu; L Zhao; Q Wang; S Zhong; X Guo; Y Zhu; J Bao; K Xu; S Liu
Journal:  Clin Transl Oncol       Date:  2021-09-15       Impact factor: 3.405

3.  Plasma exosomes exacerbate alcohol- and acetaminophen-induced toxicity via CYP2E1 pathway.

Authors:  Mohammad A Rahman; Sunitha Kodidela; Namita Sinha; Sanjana Haque; Pradeep K Shukla; Radhakrishna Rao; Santosh Kumar
Journal:  Sci Rep       Date:  2019-04-25       Impact factor: 4.379

Review 4.  Overview of Extracellular Vesicles, Their Origin, Composition, Purpose, and Methods for Exosome Isolation and Analysis.

Authors:  Laura M Doyle; Michael Zhuo Wang
Journal:  Cells       Date:  2019-07-15       Impact factor: 6.600

Review 5.  Review of the Application of Nanovesicles and the Human Interstitial Fluid in Gastrointestinal Premalignant Lesion Detection, Diagnosis, Prognosis and Therapy.

Authors:  Yu Huang; Xin Deng; Jian Liang
Journal:  Int J Nanomedicine       Date:  2019-12-02

6.  Clinical value of lncRNA CCAT1 in serum extracellular vesicles as a potential biomarker for gastric cancer.

Authors:  Ke Xiao; Zhaogang Dong; Ding Wang; Min Liu; Juan Ding; Wendan Chen; Ziqi Shang; Congbo Yue; Yi Zhang
Journal:  Oncol Lett       Date:  2021-04-06       Impact factor: 2.967

Review 7.  Long non-coding RNAs: Biogenesis, functions, and clinical significance in gastric cancer.

Authors:  Ying Liu; Wei Ding; Wanpeng Yu; Yuan Zhang; Xiang Ao; Jianxun Wang
Journal:  Mol Ther Oncolytics       Date:  2021-11-11       Impact factor: 7.200

8.  Blood cell-derived extracellular vesicles: diagnostic biomarkers and smart delivery systems.

Authors:  Limei Xu; Yujie Liang; Xiao Xu; Jiang Xia; Caining Wen; Peng Zhang; Li Duan
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

Review 9.  Exosomes Regulate NLRP3 Inflammasome in Diseases.

Authors:  Zhangwang Li; Xinyue Chen; Junjie Tao; Ao Shi; Jing Zhang; Peng Yu
Journal:  Front Cell Dev Biol       Date:  2022-01-03

10.  Predictive role of UCA1-containing exosomes in cetuximab-resistant colorectal cancer.

Authors:  Ying-Nan Yang; Rui Zhang; Jing-Wen Du; Heng-Heng Yuan; Yan-Jing Li; Xiao-Li Wei; Xiao-Xue Du; Shu-Lin Jiang; Yu Han
Journal:  Cancer Cell Int       Date:  2018-10-22       Impact factor: 5.722

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.